iTech Medical, Inc. Announces Upgrade in OTC Designation

(FORT LAUDERDALE, Fla., June xx, 2012) – iTech Medical, Inc. (OTC: IMSU - News) (FWB: 0IM - News), is engaged in the research and commercial development of healthcare information systems and technologies announced today the company has now been upgraded to "CURRENT INFORMATION" by OTC Markets. IMSU follows the international Reporting Standard or the Alternative Reporting Standard by making filings publicly available through the OTC Disclosure & News Service. To view these filings please go to www.otcmarkets.com/stock/IMSU/financials.

 

Read more...
 
MesoCoat Secures Supply Contract for PComP Coating Materials

Abakan Inc. (OTCQB: ABKI) is pleased to announce that its 71% controlled subsidiary, MesoCoat, has secured a supply contract for its PComP™ nanocomposite coating materials from a large industrial pump manufacturer and distributor in Canada. This supply contact further validates the superior value of MesoCoat’s PComP™ nanocomposite coatings in the $1+ billion North American tungsten carbide thermal spray powder coating market. Robert Miller, CEO, Abakan Inc., stated: “MesoCoat received this contract after completing extensive field testing and qualification which confirmed the superior properties of our tungsten carbide (WC) based PComP nanocomposite cermet materials, compared to other commercially available coating materials. Several variants of our PComP coatings have been under lab and field testing with the largest oilfield, pump, mining equipment, and component manufacturers. The results have been excellent, and in some cases have shown up to 5X extended coating life. We have been anticipating great demand for these products given the excellent test results and its value proposition; and hence we had already begun scaling-up production of our PComP materials to meet this demand. In the very near future, we are confident of securing several other long 

Read more...
 
Acquisition of Oil and Gas Lease to Produce Oil Reserves in South Texas Announced by Bayside Corporation

DALLAS, TX--(Marketwire -04/18/12)- 

BAYSIDE CORPORATION (Pinksheets: BYSD.PK - News)

an energy exploration, development and production company building oil & gas reserves announces the acquisition of an oil and gas lease covering the Moody and West wells in Duval County, Texas.

Bayside, acting through its wholly owned subsidiary, has acquired 100% of oil and gas leases covering 181 acres and the existing 7 wells situated on the property. The wells have previously produced oil from Jackson Series sands (Government Wells and Loma Novia zones) between depths of 2,200' and 2,400'. The wells were shut-in when the previous operator passed away and have been sitting dormant since. The Company plans to rework and/or re-complete each well and return them to commercial production of oil. The lease may also afford the opportunity to drill additional development wells in the future on the property.
Read more...
 
We Can’t Wait: President Signs Memorandum to Modernize Management of Government Records
 

November 28, 2011 - Washington D.C., - Today, President Obama took the most significant steps since the Truman Administration to improve the management of federal records. Today's Presidential Memorandum directs agencies to move into a digital-based records keeping system, a move that will save taxpayer dollars, promote accountability, and increase government transparency. Today’s action delivers on a commitment the President made in September 2011 when the White House put forward the Open Government Partnership: National Action Plan for the United States.

 

Read more...
 
IsoRay Ships First GliaSite® Brain Cancer Treatment
 
November 28, 2011 - IsoRay, Inc. (Amex: ISR - News) announced today it has shipped its first GliaSite® radiation therapy system. The Company initiated sales after receiving final approval this week from the State of Washington Department of Health to manufacture its GliaSite® radiation therapy system. The GliaSite® radiation therapy system is a balloon catheter device used in the treatment of brain cancer. Having already received FDA clearance, the Washington State regulatory approval opened the door for sales of IsoRay's GliaSite® brain cancer treatment in the United States.
 
Read more...
 
IsoRay Receives Final Regulatory Approval for GliaSite® Brain Cancer Treatment
 
November 22, 2011 - IsoRay, Inc. (Amex: ISR - News) announced today it has received final approval from the State of Washington Department of Health to manufacture its GliaSite® radiation therapy system, a balloon catheter device used in the treatment of brain cancer. In conjunction with the previously announced FDA clearance, the Washington State approval represents IsoRay’s final regulatory hurdle to commence the sale of its GliaSite® brain cancer treatment in the United States. GliaSite® is a landmark technology that allows physicians to treat more brain cancer patients than ever before with internal radiation or brachytherapy.
 
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 42